Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Studying Behavior of Acanthamoeba to Develop Targeted Strategies for Preventing Acanthamoeba Keratitis
Published on: September 20, 2024
Use of Vivostat PRF® in Acanthamoeba keratitis
Emma Marín-Payá1, Miriam Rahhal-Ortuño1, Marina Aguilar-González1
1Department of Ophthalmology, Hospital Universitari i Politecnic La Fe, Valencia, Spain.
Abstract:
We present a case of a 27-year-old contact lens male user who was diagnosed with Acanthamoeba keratitis. Given the inefficiency of medical treatment and high risk of corneal perforation, we decided to use Vivostat PRF®, with satisfactory results. To our knowledge, this is the first described case in medical literature in which Vivostat PRF® is used as part of Acanthamoeba keratitis treatment.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention

